Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-Pen vs GlucaGen for Hypoglycemia Rescue in T1D
NCT03738865Phase 3Completed
- Sponsor
- Xeris Biopharma Holdings, Inc.
- Start
- Sep 2018
- Primary completion
- Mar 2019
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 3
01
Overview
A Phase 3 trial of G-Pen in hypoglycaemia, sponsored by Xeris Biopharma Holdings, Inc.. Started Sep 2018; status: completed.
02
Drugs
G-Pen
03
Conditions
hypoglycaemia
Beyond the preview
Go deeper on NCT03738865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03738865.